.....at least an effort has been made in communicating the complexity of the manufacturing process to share holders with a whole paragraph about the cruciality of Quality analysis and product characterization. Thumbs up for that.....but it'd be of small consolation if this whole process fails again and the possibility of a clinical trial is pushed further into ......the distance
GLTH
Ann: Appendix 4E and 2024 Annual Report, page-2
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.34M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.6¢ | $4.121K | 653.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 247424 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 4883674 | 4 |
View Market Depth
| Last trade - 15.07pm 01/10/2024 (20 minute delay) ? |
| PAB (ASX) Chart |